CRISPR THERAPEUTIC earnings per share and revenue

1CG earnings per share for the last quarter are -1.29 CHF whereas the estimation was -1.23 CHF which accounts for -5.08% surprise. Företagets omsättning för samma period uppgår till 454.67 k CHF trots den uppskattade siffran 20.79 M CHF. Estimated earnings per share for the next quarter are -1.38 CHF, and revenue is expected to reach 5.58 M CHF. Also watch annual changes over time to get a bigger picture of 1CG earnings per share and revenue dynamics.